Inici › Diabetis tipus 2 › Illinois › Chicago
Assaigs clínics de Diabetis tipus 2 a Chicago, IL
19 estudis de Diabetis tipus 2 busquen participants en centres de Chicago i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
ReclutantFase 3
- Cedar Crosse Research Center, Chicago
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
ReclutantVoluntaris sans benvinguts
- Northwestern University, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ReclutantFase 3
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
ReclutantFase 3
- Research Site, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
ReclutantFase 3
- Research Site, Chicago
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
ReclutantFase 2
- AES - DRS - Synexus Clinical Research US, Inc. - Chicago, Chicago
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
ReclutantFase 2
- Cedar-Crosse Research Center, Chicago
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
ReclutantFase 2
- Research by Design, LLC - Internal Medicine, Chicago
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
ReclutantFase 2
- Chicago Clinical Research Institute, Chicago
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
ReclutantFase 3
- Research Site, Chicago
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
ReclutantFase 3
- Research Site, Chicago
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
ReclutantFase 1Voluntaris sans benvinguts
- Research Site, Chicago
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
ReclutantFase 3
- University of Illinois at Chicago, Chicago
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Reclutant
- Northwestern University, Chicago
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Reclutant
- Northwestern University, Chicago
Achieving Routine Intervention and Screening for Emotional Health
Reclutant
- University of Chicago, Chicago
Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
ReclutantEstudi observacional
- Illinois Institute of Technology, Chicago
Enhancing Diabetes Care: Exposome &Amp; Sensors
ReclutantEstudi observacional
- University of Illinois - Chicago, Chicago
- University of Illinois College of Nursing, Chicago
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
ReclutantVoluntaris sans benvinguts
- University of Illinois at Chicago, Chicago
Assaigs de Diabetis tipus 2 en altres ciutats
- San Antonio, TX37 estudis
- Houston, TX31 estudis
- Orlando, FL24 estudis
- Boston, MA20 estudis
- Miami, FL19 estudis
- Dallas, TX19 estudis
- Columbus, OH18 estudis
- Las Vegas, NV18 estudis
- Atlanta, GA17 estudis
- San Diego, CA17 estudis
- Los Angeles, CA16 estudis
- New York City, NY16 estudis
Altres estudis a Chicago
- Càncer de pulmó de cèl·lules no petites61 estudis
- Càncer de mama58 estudis
- Càncer (tots els tipus)51 estudis
- Càncer metastàtic45 estudis
- Càncer de pròstata45 estudis
- Obesitat41 estudis
- Càncer de pulmó41 estudis
- Càncer d'ovari36 estudis
- Ictus34 estudis
- Càncer colorrectal33 estudis
- Insuficiència cardíaca31 estudis
- Sobrepès28 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.